The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Frequency of Lupus Anticoagulant in Systemic Lupus Erythematosus: A Study of Sixty Consecutive Patients by Activated Partial Thromboplastin Time, Russell Viper Venom Time, and Anticardiolipin Antibody Level
Abstract
Recent reviews have suggested a higher frequency of the lupus anticoagulant or related antiphospholipid antibodies in patients with systemic lupus erythematosus (21% to 65%) than was found in earlier studies (6% to 18%). In our study of 60 consecutive patients, we found the frequency of the lupus anticoagulant by Russell viper venom time was 6.7% (95% confidence interval, 16.2 to 1.8) and by anticardiolipin antibody assay was 25% (95% Cl, 37.0 to 15.7), compared with 0% (p = not significant) and 2.5% (p = 0.002), respectively, in the normal control population. The Russell viper venom time (p = 0.0001 by t-test) and anticardiolipin antibody levels (p = 0.01) were significantly associated with presumed thrombotic events (stroke, deep venous thrombosis, and digital gangrene). No association with miscarriage or pulmonary hypertension was detected. The Russell viper venom time was more specific than the anticardiolipin antibody level in the prediction of past presumed thrombotic events, miscarriage, or pulmonary hypertension (100% compared with 84%, p = 0.01).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., & Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6398.1021 · Cited by 508
Cited by
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Pehamberger, H., Steiner, A., & Wolff, K. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70239-4 · Cited by 634
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez-Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 624
Self-citationImmunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Epidemiology of the Antiphospholipid Antibody Syndrome
Petri, M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0409 · Cited by 472
Self-citation
Metadata
- Authors
- PETRI, M., RHEINSCHMIDT, M., WHITING-O'KEEFE, Q., HELLMANN, D., & CORASH, L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1987-04-01
- Volume
- 106
- Issue
- 4
- Pages
- 524-531
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2046324501
- Cited by
- 232
- References
- 2
- FWCI
- 21.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Frequency of Lupus Anticoagulant in Systemic Lupus Erythematosus: A Study of Sixty Consecutive Patients by Activated Partial Thromboplastin Time, Russell Viper Venom Time, and Anticardiolipin Antibody Level. https://app.cochat.ai/papers/10.7326/0003-4819-106-4-524
- The paper
- PETRI, M., RHEINSCHMIDT, M., WHITING-O'KEEFE, Q., HELLMANN, D., & CORASH, L. (1987). The Frequency of Lupus Anticoagulant in Systemic Lupus Erythematosus: A Study of Sixty Consecutive Patients by Activated Partial Thromboplastin Time, Russell Viper Venom Time, and Anticardiolipin Antibody Level. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-106-4-524
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.